Literature DB >> 32383233

Flow Rate Affects Nanoparticle Uptake into Endothelial Cells.

Yih Yang Chen1,2, Abdullah Muhammad Syed1,2, Presley MacMillan1,2,3, Jonathan V Rocheleau1,4,5, Warren C W Chan1,2,6,7,3.   

Abstract

Nanoparticles are commonly administered through systemic injection, which exposes them to the dynamic environment of the bloodstream. Injected nanoparticles travel within the blood and experience a wide range of flow velocities that induce varying shear rates to the blood vessels. Endothelial cells line these vessels, and have been shown to uptake nanoparticles during circulation, but it is difficult to characterize the flow-dependence of this interaction in vivo. Here, a microfluidic system is developed to control the flow rates of nanoparticles as they interact with endothelial cells. Gold nanoparticle uptake into endothelial cells is quantified at varying flow rates, and it is found that increased flow rates lead to decreased nanoparticle uptake. Endothelial cells respond to increased flow shear with decreased ability to uptake the nanoparticles. If cells are sheared the same way, nanoparticle uptake decreases as their flow velocity increases. Modifying nanoparticle surfaces with endothelial-cell-binding ligands partially restores uptake to nonflow levels, suggesting that functionalizing nanoparticles to bind to endothelial cells enables nanoparticles to resist flow effects. In the future, this microfluidic system can be used to test other nanoparticle-endothelial cell interactions under flow. The results of these studies can guide the engineering of nanoparticles for in vivo medical applications.
© 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Keywords:  blood vessels; flow shear; flow velocity; microfluidics; nanomedicine; nanoparticles

Mesh:

Substances:

Year:  2020        PMID: 32383233     DOI: 10.1002/adma.201906274

Source DB:  PubMed          Journal:  Adv Mater        ISSN: 0935-9648            Impact factor:   30.849


  5 in total

1.  Dual Affinity to RBCs and Target Cells (DART) Enhances Both Organ- and Cell Type-Targeting of Intravascular Nanocarriers.

Authors:  Laura T Ferguson; Elizabeth D Hood; Tea Shuvaeva; Vladimir V Shuvaev; Maria C Basil; Zhicheng Wang; Jia Nong; Xiaonan Ma; Jichuan Wu; Jacob W Myerson; Oscar A Marcos-Contreras; Jeremy Katzen; Justine M Carl; Edward E Morrisey; Edward Cantu; Carlos H Villa; Samir Mitragotri; Vladimir R Muzykantov; Jacob S Brenner
Journal:  ACS Nano       Date:  2022-03-10       Impact factor: 18.027

Review 2.  Understanding Nanomaterial-Liver Interactions to Facilitate the Development of Safer Nanoapplications.

Authors:  Jiulong Li; Chunying Chen; Tian Xia
Journal:  Adv Mater       Date:  2022-02-03       Impact factor: 32.086

3.  Development of Microfluidic, Serum-Free Bronchial Epithelial Cells-on-a-Chip to Facilitate a More Realistic In vitro Testing of Nanoplastics.

Authors:  Govind Gupta; Srikanth Vallabani; Romain Bordes; Kunal Bhattacharya; Bengt Fadeel
Journal:  Front Toxicol       Date:  2021-10-06

Review 4.  Overcoming Vascular Barriers to Improve the Theranostic Outcomes of Nanomedicines.

Authors:  Yufu Tang; Zhongzheng Yu; Xiaomei Lu; Quli Fan; Wei Huang
Journal:  Adv Sci (Weinh)       Date:  2022-03-04       Impact factor: 17.521

Review 5.  Tumor-on-a-chip model for advancement of anti-cancer nano drug delivery system.

Authors:  Chutong Tian; Shunzhe Zheng; Xinying Liu; Ken-Ichiro Kamei
Journal:  J Nanobiotechnology       Date:  2022-07-20       Impact factor: 9.429

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.